| 000 | 01072 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514043113.0 | ||
| 264 | 0 | _c20030514 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0360-2532 | ||
| 024 | 7 |
_a10.1081/dmr-120005650 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZiegler, Daniel M | |
| 245 | 0 | 0 |
_aAn overview of the mechanism, substrate specificities, and structure of FMOs. _h[electronic resource] |
| 260 |
_bDrug metabolism reviews _cAug 2002 |
||
| 300 |
_a503-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aOxygenases _xchemistry |
| 650 | 0 | 4 | _aProtein Structure, Tertiary |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aXenobiotics _xmetabolism |
| 773 | 0 |
_tDrug metabolism reviews _gvol. 34 _gno. 3 _gp. 503-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/dmr-120005650 _zAvailable from publisher's website |
| 999 |
_c12095362 _d12095362 |
||